Loading clinical trials...
Loading clinical trials...
The main purpose of this study is to investigate the safety of the investigational drug DCC-2701 and whether it will work to help people who have advanced solid tumors or cancer that has spread to oth...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Deciphera Pharmaceuticals, LLC
NCT03093116 · Locally Advanced Solid Tumors, Metastatic Solid Tumors
NCT06248411 · Advanced or Metastatic Solid Tumors
NCT06716138 · Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration
NCT06307795 · Locally Advanced or Metastatic Solid Tumors
NCT05753722 · Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer, and more
University of Colorado Hospital
Aurora, Colorado
Massachusetts General Hospital
Boston, Massachusetts
The Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions